Strategy
MSTR
Meta Platforms
META
Oracle
ORCL
Amazon
AMZN
Salesforce
CRM
US Stock MarketDetailed Quotes
SNY Sanofi
- 54.950
- +0.060+0.11%
Close Feb 26 16:00 ET
- 54.810
- -0.140-0.25%
Pre 05:33 ET
137.77BMarket Cap23.66P/E (TTM)
55.200High54.570Low1.82MVolume54.600Open54.890Pre Close100.21MTurnover0.08%Turnover Ratio23.66P/E (Static)2.51BShares58.97052wk High1.70P/B124.47BFloat Cap43.38152wk Low1.95Dividend TTM2.27BShs Float58.970Historical High3.55%Div YieldTTM1.15%Amplitude8.844Historical Low54.962Avg Price1Lot Size
About Sanofi Company
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
Company Profile
SymbolSNY
Company NameSanofi
Founded1994
CEOMr. Paul Hudson
MarketNASDAQ
Employees82878
Securities TypeDR
ADS Ratio2.0 : 1.0
Fiscal Year Ends12-31
Address46, avenue de la Grande Armée
CityParis
ProvinceIle-de-France
CountryFrance
Zip Code75017
Phone33-1-53-77-40-00
Websitehttp://www.sanofi.com
Company Executives
- Name
- Position
- Salary
- Paul Hudson
- Director and Chief Executive Officer
- --
- Francois-Xavier Roger
- Executive Vice President and Chief Financial Officer
- --
- Emmanuel Frenehard
- Executive Vice President and Chief Digital Officer
- --
- Natalie Bickford
- Executive Vice President and Chief People Officer
- --
- Audrey Duval
- Executive Vice President, Corporate Affairs
- --
- Brendan O'Callaghan
- Executive Vice President, Global Manufacturing & Supply
- --
- Thomas Triomphe
- Executive Vice President, Vaccines
- --
- Madeleine Roach
- Executive Vice President, Business Operations
- --
- Olivier Charmeil
- Executive Vice President, General Medicines
- --
- Roy Papatheodorou
- Executive Vice President and General Counsel
- --
- Brian Foard
- Executive Vice President, Specialty Care
- --
- Houman Ashrafian
- Executive Vice President and Head of Research and Development
- --
- Julie Van Ongevalle
- Executive Vice President, Consumer Healthcare
- --
- Frederic Oudea
- Chairman of the Board
- --
- Christophe Babule
- Director
- 162.00K
- Yann Tran
- Director
- 112.50K
- Wolfgang Laux
- Director
- 129.00K
- Barbara Lavernos
- Director
- 156.50K
- Carole Ferrand
- Independent Director
- 197.75K
- John Sundy
- Independent Director
- 113.50K
- Emile Voest
- Independent Director
- 159.25K
- Lise Kingo
- Independent Director
- 167.50K
- Anne-Francoise Nesmes
- Independent Director
- 124.50K
- Patrick Kron
- Independent Director
- 195.00K
- Rachel Duan
- Independent Director
- 145.50K
- Fabienne Lecorvaisier
- Independent Director
- 170.25K
- Jean-Paul Kress
- Independent Director
- --
- Clotilde Delbos
- Independent Director
- 124.50K
- Dr. Antoine Yver, M.D.,M.Sc.
- Independent Director
- 184.00K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
